MicroRNA‐483 amelioration of experimental pulmonary hypertension

Endothelial dysfunction is critically involved in the pathogenesis of pulmonary arterial hypertension (PAH) and that exogenously administered microRNA may be of therapeutic benefit. Lower levels of miR‐483 were found in serum from patients with idiopathic pulmonary arterial hypertension (IPAH), part...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:EMBO Mol Med
Auteurs principaux: Zhang, Jin, He, Yangyang, Yan, Xiaosong, Chen, Shanshan, He, Ming, Lei, Yuyang, Zhang, Jiao, Gongol, Brendan, Gu, Mingxia, Miao, Yifei, Bai, Liang, Cui, Xiaopei, Wang, Xiaojian, Zhang, Yixin, Fan, Fenling, Li, Zhao, Shen, Yuan, Chou, Chih‐Hung, Huang, Hsien‐Da, Malhotra, Atul, Rabinovitch, Marlene, Jing, Zhi‐Cheng, Shyy, John Y‐J
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2020
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7207157/
https://ncbi.nlm.nih.gov/pubmed/32324970
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201911303
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires